ethylestrenol has been researched along with metformin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chakrabarti, R; Fearnley, GR; Hocking, ED | 1 |
Chakrabarti, R; Evans, JF; Fearnley, GR | 1 |
Chakrabarti, R; Fearnley, GR | 1 |
Chakrabarti, R | 1 |
Gormsen, J | 1 |
Fearnley, GR | 2 |
Chakrabarti, R; Evans, J; Fearnley, GR; Hocking, ED | 1 |
1 trial(s) available for ethylestrenol and metformin
Article | Year |
---|---|
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases | 1967 |
8 other study(ies) available for ethylestrenol and metformin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
Topics: Aged; Anticholesteremic Agents; Blood Coagulation Tests; Blood Platelets; Butyrates; Cholesterol; Coronary Disease; Ethylestrenol; Female; Fibrinolysis; Humans; Intracranial Embolism and Thrombosis; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Vascular Diseases | 1968 |
Pharmacological fibrinolysis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Clofibrate; Delayed-Action Preparations; Drug Resistance; Drug Therapy, Combination; Ethylestrenol; Female; Fibrin; Fibrinolysis; Humans; Male; Metformin; Methadone; Nandrolone; Phenformin; Stimulation, Chemical; Sulfonylurea Compounds; Testosterone; Time Factors | 1972 |
Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
Topics: Administration, Oral; Arterial Occlusive Diseases; Cholesterol; Drug Therapy, Combination; Ethylestrenol; Fibrinogen; Fibrinolysis; Follow-Up Studies; Glass; Humans; Metformin; Methods; Phenformin; Platelet Adhesiveness; Stanozolol; Time Factors | 1972 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation Tests; Blood Platelets; Clofibrate; Coronary Disease; Diabetes Mellitus; Ethylestrenol; Fibrinolysis; Humans; Insulin; Metformin; Myocardial Infarction; Phenformin; Sulfonylurea Compounds; Testosterone; Thrombosis | 1971 |
Fibrinolytic effect of biguanides.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis Obliterans; Biguanides; Chlorpropamide; Coronary Disease; Ethylestrenol; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Metformin; Methenolone; Middle Aged; Phenformin; Tolbutamide | 1968 |
Pharmacological fibrinolysis.
Topics: Aged; Androsterone; Anticholesteremic Agents; Butyrates; Chlorpropamide; Coronary Disease; Ethylestrenol; Female; Fibrinogen; Fibrinolysis; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Phenformin; Platelet Adhesiveness; Tolbutamide | 1969 |